Table 2.
Assessment Points | Outcome | Sample | n | g | 95% CI | Se | z | Q | I2 | Duval and Tweedie | |
---|---|---|---|---|---|---|---|---|---|---|---|
Pre-FU III | PTSS | All studies | 13 | (1.98) 1.71 a | (1.53–2.43) 1.27–2.15 | (.23) | (8.66***) | 117.65*** | 89.80 | 3 | |
Individual | 8 | 1.63 | 1.07–2.19 | .29 | 5.67*** | 61.76*** | 88.67 | 0 | |||
Group | 5 | 2.47 b | 2.25–2.69 | .11 | 21.81*** | 6.87 | 41.79 | 0 | |||
RCTs only | 12 | (1.93) 1.71 a | (1.46–2.39) 1.24–2.18 | (.24) | (8.08***) | 109.86*** | 89.99 | 2 | |||
Efficacy | 6 | 1.69 | .80–2.57 | .46 | 3.74*** | 60.95*** | 91.80 | 0 | |||
Effectiveness | 6 | (2.16) 2.00 a | (1.69–2.62) 1.53–2.47 | (.24) | (9.10***) | 31.86*** | 84.31 | 1 | |||
Individual | 8 | 1.63 | 1.07–2.19 | .29 | 5.67*** | 61.76*** | 88.67 | 0 | |||
Group | 4 | 2.44 b | 2.20–2.68 | .12 | 19.91*** | 6.41 | 53.18 | 0 | |||
Depression | All studies | 9 | .99 | .70–1.29 | .15 | 6.55*** | 37.48*** | 78.65 | 0 | ||
RCTs only | 8 | .90 | .63–1.17 | .14 | 6.46*** | 23.86** | 70.66 | 0 | |||
Anxiety | All studies | 6 | .95 | .55–1.35 | .20 | 4.69*** | 29.84*** | 83.25 | 0 | ||
RCTs only | 6 | .95 | .55–1.35 | .20 | 4.69*** | 29.84*** | 83.25 | 0 | |||
Grief | All studies | 6 | (1.73) 1.44 a | (1.29–2.18) .94–1.94 | (.23) | (7.62***) | 28.67*** | 82.56 | 2 | ||
RCTs only | 5 | (1.61) 1.44 a | (1.12–2.10) .91–1.97 | (.25) | (6.47***) | 24.24*** | 83.50 | 1 | |||
FU II-FU III | PTSS | All studies | 7 | .20 b | .07–.33 | .07 | 3.05** | 1.68 | 0 | 0 | |
Depression | All studies | 7 | .09 b | −.04–.21 | .06 | 1.37 | 3.25 | 0 | 0 | ||
Anxiety | All studies | 5 | .12 | −.02–.26 | .07 | 1.70 | 3.65 | 0 | 0 |
Note. High risk of bias studies are excluded; n = number of included TF-CBT conditions. *p < .05; **p < .01; ***p < .001.
aRecalculated with imputed studies (trim and fill method according to Duval and Tweedie).
bFixed model assumed due to non-significant Q-value.